Oxcarbazepine extended-release formulation in epilepsy.
1Epilepsiezentrum Kork, Landstr. 1, D-77694 Kehl-Kork, Germany. bsteinhoff@epilepsiezentrum.de.
Expert Review of Clinical Pharmacology
|January 14, 2014
Summary
Oxcarbazepine (OXC) immediate-release (IR) and extended-release (ER) formulations show similar efficacy, but ER OXC may offer improved tolerability by reducing peak plasma concentrations and fluctuations. Further studies are ongoing to compare their long-term tolerability.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Neurology
Background:
- Oxcarbazepine (OXC), a carbamazepine analogue, offers similar efficacy with fewer drug interactions due to its nonoxidative metabolism.
- OXC acts as a prodrug, rapidly converted to its active monohydroxylated derivative (MHD).
- Immediate-release (IR) OXC formulations can lead to side effects due to peak plasma concentrations.
Purpose of the Study:
- To compare the pharmacokinetic and clinical profiles of immediate-release (IR) and extended-release (ER) oxcarbazepine formulations.
- To evaluate the impact of ER formulation on reducing peak plasma concentrations and fluctuations of OXC and MHD.
- To assess the comparative efficacy and tolerability of IR versus ER OXC formulations in epilepsy patients.
Main Methods:
- Phase I studies to establish bioequivalence between IR and ER OXC under steady-state conditions.
- Clinical trials comparing IR OXC (twice daily) versus ER OXC (once daily) in terms of efficacy and tolerability.
- An ongoing study comparing the tolerability of IR and ER OXC under twice-daily administration in patients requiring dosage increases.
Main Results:
- Phase I studies confirmed bioequivalence between IR and ER OXC.
- ER OXC significantly reduces OXC and MHD peak plasma concentrations and peak-trough fluctuations compared to IR formulations.
- Clinical trials showed no significant differences in efficacy between IR and ER OXC, with ER OXC demonstrating slight, non-significant tolerability advantages.
Conclusions:
- The extended-release (ER) formulation of oxcarbazepine (OXC) provides a pharmacokinetic profile that may mitigate side effects associated with peak plasma concentrations.
- While both immediate-release (IR) and ER OXC formulations demonstrate comparable efficacy, ER OXC presents potential tolerability benefits.
- Ongoing research will further elucidate the comparative tolerability of IR and ER OXC, particularly in patients requiring higher dosages.
Related Concept Videos
01:20Antiepileptic Drugs: Potassium Channel Activators
1.0K
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
1.0K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
01:17Antiepileptic Drugs: Calcium Channel Blockers
1.7K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.7K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.7K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
01:08Antiepileptic Drugs: Sodium Channel Blockers
2.4K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.4K
01:14Antiepileptic Drugs: Glutamate Antagonists
1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K